Le Lézard
Classified in: Business, Covid-19 virus
Subject: ATY

Levi & Korsinsky Reminds Amplitude, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 15, 2024 - AMPL


NEW YORK, April 10, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Amplitude, Inc. ("Amplitude" or the "Company") (NASDAQ: AMPL) of a class action securities lawsuit.

CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Amplitude investors who were adversely affected by alleged securities fraud between September 21, 2021 and February 16, 2022. Follow the link below to get more information and be contacted by a member of our team:

https://zlk.com/pslra-1/amplitude-lawsuit-submission-form?prid=74893&wire=4

AMPL investors may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500.

CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that:  (a) Amplitude's land-and-expand strategy was years away from significantly accelerating revenues among its newer client cohorts; (b) the rapid acceleration in the Company's 2Q21 results resulted from the ephemeral effects of the COVID-19 pandemic which had not continued by the start of the class period, as Amplitude clients were expanding at a slower pace; and (c) as a result of (a)-(b) above, Amplitude's business, operations, financial results, and prospects were materially worse than represented to investors during the class period.

WHAT'S NEXT? If you suffered a loss in Amplitude during the relevant time frame, you have until April 15, 2024 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate.

WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 17th Floor
New York, NY 10004
[email protected]
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE Levi & Korsinsky, LLP


These press releases may also interest you

at 12:45
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against QuidelOrtho Corporation ("QuidelOrtho" or the "Company") and reminds investors of the June 11, 2024 deadline to seek the role of lead plaintiff...

at 12:40
The "Global AI Text Generator Market: Analysis By Component, By Application, By End User, By Region Size and Trends with Impact of COVID-19 and Forecast up to 2029" report has been added to ResearchAndMarkets.com's offering. The global AI text...

at 11:56
Owner Brian Flowers (Table Top Café) and partners Jonathan Comeau and Adam Stoyko (Wafflebird, Dining Car Café) team up to create a new board gaming space in one of Edmonton's most vibrant cultural districts. The grand opening event holds special...

at 11:20
The "Microneedle Flu Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F" report has been added to ResearchAndMarkets.com's offering. Global Microneedle Flu Vaccine Market was valued at USD 1.10 Billion in...

at 11:00
Glancy Prongay & Murray LLP ("GPM") announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against QuidelOrtho Corporation ("QuidelOrtho" or the "Company") . Class Period: February 18,...

at 10:23
The American Telemedicine Association (ATA) today announced that Sree Chaguturu, MD, has become Chair of the Board of Directors. Dr. Chaguturu is Executive Vice President and Chief Medical Officer, CVS Health®, where he leads the enterprise medical...



News published on and distributed by: